acetylation
Showing 1 - 25 of 247
Assessing Causality of CREBBP and EP300 Variants.
Recruiting
- Rubinstein-Taybi Syndrome
- skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
- +4 more
-
Talence, FranceCentre Hospitalier Universitaire de Bordeaux
Oct 7, 2021
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
Recruiting
- Tuberculosis
-
Amiens, Picardie, FranceCHU Amiens Picardie
Sep 28, 2023
Type2 Diabetes, Insulin Resistance Trial in Odense (Acute exercise)
Completed
- Type2 Diabetes
- Insulin Resistance
- High intensity interval training
-
Odense, DenmarkDepartment of Endocrinology, Odense University Hospital
Aug 31, 2022
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Parkinson Disease Trial in Bergen (Nicotinamide Riboside, Placebo)
Recruiting
- Parkinson Disease
- Nicotinamide Riboside
- Placebo
-
Bergen, Vestland, NorwayHaukeland University Hospital
Nov 28, 2022
Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Sodium Valproate
- +2 more
-
Saint Leonards, New South Wales, Australia
- +8 more
Jan 22, 2023
Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
-
Fairfax, VirginiaNEXT Oncology
Jun 7, 2023
Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside
Recruiting
- Alzheimer Disease
- Dementia
- Placebo
- +2 more
-
Bergen, Vestland, Norway
- +1 more
Nov 25, 2022
Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,
Not yet recruiting
- Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
- +5 more
- Belinostat
- +2 more
- (no location specified)
Dec 2, 2022
Ketosis, Type 2 Diabetes Trial in Kelowna (Ketone monoester, Placebo)
Completed
- Ketosis
- Type 2 Diabetes
- Ketone monoester
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan
Jul 29, 2022
Post-translational Modifications to Circulating Histones Via
Active, not recruiting
- Pregnancy Related
- Pre-Eclampsia
- Analysis of post-translational histone modifications via mass spectrometry
-
Nîmes, Gard, FranceNîmes University Hospital
Dec 1, 2021
Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)
Active, not recruiting
- Melanoma
- +2 more
- HBI-8000 in combination with nivolumab
-
Phoenix, Arizona
- +5 more
Jun 11, 2022
Influenza, Herpes Zoster Trial in Nijmegen (Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern
Active, not recruiting
- Influenza
- Herpes Zoster
- Herpes zoster vaccination (Shingrix, GSK)
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University
May 19, 2022
Postural Tachycardia Syndrome Trial in Nashville (NET mRNA level, Plasma catechols, Urine Catechols)
Enrolling by invitation
- Postural Tachycardia Syndrome
- NET mRNA level
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 4, 2021
Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- Fimepinostat
- Therapeutic Conventional Surgery
-
Los Angeles, California
- +18 more
Aug 16, 2022
Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,
Healthy Volunteers Trial in Grenoble (CKD-510 single dose, CKD-510 food effect, CKD-510 multiple dose)
Completed
- Healthy Volunteers
- CKD-510 single dose
- +3 more
-
Grenoble, FranceClinical site
May 2, 2022
Skin Cells That Stop Replicating During Wound Healing
Completed
- Healthy Volunteers
-
Baltimore, MarylandNational Institute on Aging, Clinical Research Unit
Feb 2, 2023
Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)
Recruiting
- Newly Diagnosed Peripheral T-cell Lymphoma
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in
Terminated
- Estrogen Receptor-negative Breast Cancer
- +6 more
- entinostat
- +3 more
-
Baltimore, MarylandUniversity of Maryland Baltimore
Apr 29, 2022
Ticagrelor and Aspirin in Acute Coronary Syndrome
Recruiting
- Acute Coronary Syndrome
-
Harbin, Heilongjiang, Chinathe first affiliated hospital of Harbin Medical University
Jun 9, 2022